Rat Recombinant Monoclonal MCPIP1 antibody. Suitable for WB and reacts with Mouse samples. Cited in 1 publication.
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
ICC | WB | IHC-P | |
---|---|---|---|
Human | Not recommended | Not recommended | Not recommended |
Mouse | Not recommended | Tested | Not recommended |
Rat | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human, Rat | Dilution info - | Notes - |
Endoribonuclease involved in various biological functions such as cellular inflammatory response and immune homeostasis, glial differentiation of neuroprogenitor cells, cell death of cardiomyocytes, adipogenesis and angiogenesis. Functions as an endoribonuclease involved in mRNA decay (PubMed:26000482). Modulates the inflammatory response by promoting the degradation of a set of translationally active cytokine-induced inflammation-related mRNAs, such as IL6 and IL12B, during the early phase of inflammation (PubMed:19322177, PubMed:21115689, PubMed:23185455, PubMed:26000482). Prevents aberrant T-cell-mediated immune reaction by degradation of multiple mRNAs controlling T-cell activation, such as those encoding cytokines (IL6 and IL2), cell surface receptors (ICOS, TNFRSF4 and TNFR2) and transcription factor (REL) (PubMed:19322177, PubMed:21115689, PubMed:23185455, PubMed:23706741, PubMed:26000482). Inhibits cooperatively with ZC3H12A the differentiation of helper T cells Th17 in lungs. They repress target mRNA encoding the Th17 cell-promoting factors IL6, ICOS, REL, IRF4, NFKBID and NFKBIZ. The cooperation requires RNA-binding by RC3H1 and the nuclease activity of ZC3H12A (PubMed:25282160). Together with RC3H1, destabilizes TNFRSF4/OX40 mRNA by binding to the conserved stem loop structure in its 3'UTR (PubMed:29244194). Self regulates by destabilizing its own mRNA (PubMed:22037600). Cleaves mRNA harboring a stem-loop (SL), often located in their 3'-UTRs, during the early phase of inflammation in a helicase UPF1-dependent manner (PubMed:19322177, PubMed:23185455, PubMed:23706741, PubMed:26000482, PubMed:26134560). Plays a role in the inhibition of microRNAs (miRNAs) biogenesis (By similarity). Cleaves the terminal loop of a set of precursor miRNAs (pre-miRNAs) important for the regulation of the inflammatory response leading to their degradation, and thus preventing the biosynthesis of mature miRNAs (By similarity). Also plays a role in promoting angiogenesis in response to inflammatory cytokines by inhibiting the production of antiangiogenic microRNAs via its anti-dicer RNase activity (By similarity). Affects the overall ubiquitination of cellular proteins (PubMed:21115689). Positively regulates deubiquitinase activity promoting the cleavage at 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains on TNF receptor-associated factors (TRAFs), preventing JNK and NF-kappa-B signaling pathway activation, and hence negatively regulating macrophage-mediated inflammatory response and immune homeostasis (PubMed:21115689). Induces also deubiquitination of the transcription factor HIF1A, probably leading to its stabilization and nuclear import, thereby positively regulating the expression of proangiogenic HIF1A-targeted genes. Involved in a TANK-dependent negative feedback response to attenuate NF-kappaB activation through the deubiquitination of IKBKG or TRAF6 in response to interleukin-1-beta (IL1B) stimulation or upon DNA damage (By similarity). Prevents stress granules (SGs) formation and promotes macrophage apoptosis under stress conditions, including arsenite-induced oxidative stress, heat shock, and energy deprivation (PubMed:21971051). Plays a role in the regulation of macrophage polarization; promotes IL4-induced polarization of macrophages M1 into anti-inflammatory M2 state (PubMed:25934862). May also act as a transcription factor that regulates the expression of multiple genes involved in inflammatory response, angiogenesis, adipogenesis and apoptosis (PubMed:18178554, PubMed:19666473, PubMed:22739135). Functions as a positive regulator of glial differentiation of neuroprogenitor cells through an amyloid precursor protein (APP)-dependent signaling pathway (By similarity). Attenuates septic myocardial contractile dysfunction in response to lipopolysaccharide (LPS) by reducing I-kappa-B-kinase (IKK)-mediated NF-kappa-B activation, and hence myocardial pro-inflammatory cytokine production (PubMed:21616078).
Mcpip, Mcpip1, Zc3h12a, Endoribonuclease ZC3H12A, Monocyte chemotactic protein-induced protein 1, Regnase-1, Zinc finger CCCH domain-containing protein 12A, MCP-induced protein 1, MCPIP-1, Reg1
Rat Recombinant Monoclonal MCPIP1 antibody. Suitable for WB and reacts with Mouse samples. Cited in 1 publication.
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
The MCPIP1 (Monocyte Chemotactic Protein-Induced Protein 1) also known by the name Regnase-1 is a protein involved in RNA degradation and inflammation regulation. It acts as an RNase specifically targeting mRNAs for degradation impacting gene expression post-transcriptionally. The protein weighs around 66 kDa and shows expression in various tissues including heart spleen and macrophages. MCPIP1 also demonstrates notable expression in response to external stimuli like lipopolysaccharides.
MCPIP1 modulates the immune response and inflammation by degrading mRNA of cytokines. Its action helps in controlling inflammation and immune response duration. MCPIP1 interacts with cellular complexes that manage mRNA stability including those involved in decay processes. This activity positions MCPIP1 as a regulator in the production of pro-inflammatory cytokines contributing to the cellular response to external pathogens.
MCPIP1 functions within the inflammatory and immune signaling pathways. It is involved in the MAPK pathway which regulates gene expression in response to stress and cytokines. MCPIP1 also interacts with proteins such as TNF-alpha and IL-6 linking it to the inflammatory signaling cascade. These interactions highlight MCPIP1's role in mediating immune and inflammatory pathways contributing to maintaining cellular homeostasis.
MCPIP1 connections relate to inflammatory diseases and autoimmune disorders. Aberrant expression or malfunction of MCPIP1 associates with pathological conditions including rheumatoid arthritis and systemic lupus erythematosus. The regulation of cytokines by MCPIP1 positions it centrally in these conditions as inappropriate levels of proteins like IL-6 and TNF-alpha contribute to disease progression. Consequently MCPIP1 serves as a potential therapeutic target in managing inflammation-driven diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID: 29263935).
Exposure time 3 minutes.
All lanes: Western blot - Anti-MCPIP1 antibody [15D11] (ab252879) at 1/1000 dilution
Lane 1: Untreated RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage), whole cell lysate at 20 µg
Lane 2: RAW264.7 treated with 100ng/ml LPS (Lipopolysaccharide) for 4 hours, whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rat IgG H&L (HRP) (Goat Anti-Rat IgG H&L (HRP) ab205720) at 1/5000 dilution
Predicted band size: 65 kDa
Observed band size: 65 kDa
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
Exposure time 20 seconds.
All lanes: Western blot - Anti-MCPIP1 antibody [15D11] (ab252879) at 1/1000 dilution
All lanes: F9 (mouse embryonal carcinoma epithelial cell), whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rat IgG H&L (HRP) (Goat Anti-Rat IgG H&L (HRP) ab205720) at 1/5000 dilution
Predicted band size: 65 kDa
Observed band size: 65 kDa
4-15% gel. Blocking was done using 5% milk for 1 hour at 25°C
All lanes: Western blot - Anti-MCPIP1 antibody [15D11] (ab252879) at 1/1000 dilution
All lanes: MEFs whole cell lysate
All lanes: HRP Donkey anti-rat at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Exposure time: 3min
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com